Page last updated: 2024-09-03

rc 3095 and interleukin-8

rc 3095 has been researched along with interleukin-8 in 1 studies

Compound Research Comparison

Studies
(rc 3095)
Trials
(rc 3095)
Recent Studies (post-2010)
(rc 3095)
Studies
(interleukin-8)
Trials
(interleukin-8)
Recent Studies (post-2010) (interleukin-8)
10822623,5231,1679,990

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarenga, DM; Antunes, MM; Bonorino, C; Czepielewski, RS; da Silva, RD; da Silva, VD; Jaeger, N; Lopes, TG; Marques, PE; Menezes, GB; Pereira, RV; Porto, BN; Rigo, MM1

Other Studies

1 other study(ies) available for rc 3095 and interleukin-8

ArticleYear
GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility.
    European journal of immunology, 2017, Volume: 47, Issue:4

    Topics: Animals; Bombesin; Cell Movement; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chemotaxis; Humans; Interleukin-8; Mice; Mice, Inbred Strains; Neutrophil Activation; Neutrophils; Peptide Fragments; Protein Binding; Receptors, Bombesin; Receptors, Interleukin-8B; Signal Transduction

2017